Accessibility Menu
Integer logo

Integer(NYSE) ITGR

Market Cap$4.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+501%
5 Year+27%
1 Year+16%
1 Month+25%
Premium Feature
Moneyball Superscore
66/100
$125.32
+0.10%
+0.13Today
After hours$125.30-$0.02 (-0.02%)
Integer last closing stock price
MetricPriceDate
Last closeUSD 125.302026-08-27
Integer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.07%USD 125.212026-08-20
1 month+24.83%USD 100.382026-07-28
3 month+40.19%USD 89.382026-05-29
Year to date+59.76%USD 78.432025-12-31
1 year+15.94%USD 108.072025-08-27
3 year+52.77%USD 82.022023-08-28
5 year+27.47%USD 98.302021-08-27
Since inception+501.14%USD 20.842000-09-29

Integer Financials at a Glance

Market Cap

$4.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.84B

Net Income (TTM)

$128.40M

EPS (TTM)

$3.67

P/E Ratio

34.16

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$125.32

Volume

461,012.931

Open

$125.32

Previous Close

$125.30

Daily Range

$125.29 - $125.46

52-Week Range

$62.00 - $126.14

Estimated Earnings Date

Oct 22, 2026

ITGR: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Integer

Integer Holdings Corporation makes parts for medical devices. It helps doctors treat patients with pacemakers and surgical tools. Its products solve health problems and support military technology.

What Integer Builds

  • Cardio and Vascular: Provides parts for heart and blood vessel procedures; sales were $280.3 million in the second quarter of 2026.
  • Cardiac Rhythm and Neuromodulation: Supplies components for pacemakers and pain management devices; sales were $173.7 million in the second quarter of 2026.
  • Other Markets: Builds battery systems for energy and military clients; sales were $10.1 million in the second quarter of 2026.

Strategic Moves and Mergers

  • Acquired Biocoat on Dec. 4, 2025, to add specialized medical coating technologies.
  • Purchased VSi on Feb. 28, 2025, to add parylene coating solutions for medical devices.
  • Added Precision on Jan. 7, 2025, to expand surface coating and laser processing capabilities.
  • Entered an agreement on Aug. 2, 2026, to be acquired by affiliates of Kohlberg Kravis Roberts and Company for $127 per share in cash.

A Global Manufacturing Partner

Integer serves as a strategic partner to major medical device companies. These companies, known as original equipment manufacturers, sell finished products using components Integer builds. Integer operates as a contract development and manufacturing organization. This means it handles the engineering and production work for its clients.

Recent Financial Results

  • Sales were $464.1 million in the second quarter of 2026, down 2.6% year over year.
  • Income from continuing operations was $40.1 million in the first six months of 2026, up 175.8% year over year.
  • Gross profit was $112.9 million in the second quarter of 2026, down 12.6% year over year.
  • The company held $21.4 million in cash and cash equivalents as of July 3, 2026.

Bottom Line

Integer has transitioned from a component supplier to a comprehensive partner for medical device companies. Its focus on specialized coatings and core medical markets supports its role in the global healthcare supply chain.

AI Generated • Aug 5, 2026

Industry

Healthcare Equipment and Supplies

Employees

11,000

CEO

Payman Khales, EMBA

Headquarters

Plano, TX 75024, US

ITGR Financials

Key Financial Metrics (TTM)

Gross Margin

23.73%

Operating Margin

9.47%

Net Income Margin

6.97%

Return on Equity

7.43%

Return on Capital

6.65%

Return on Assets

3.75%

Earnings Yield

2.93%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

33.99M

Volume

461.01K

Avg. Volume

860.43K

Financials (TTM)

Gross Profit

$436.92M

Operating Income

$174.40M

EBITDA

$313.03M

Operating Cash Flow

$205.44M

Capital Expenditure

-$93.46M

Free Cash Flow

$111.98M

Cash & ST Invst.

$21.38M

Total Debt

$1.36B

Integer Performance Analysis

Integer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,378,169,00012.8%
20232023-12-31USD 1,554,726,00012.8%
20242024-12-31USD 1,719,849,00010.6%
20252025-12-31USD 1,846,466,0007.4%
Integer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-26-1.3%
Q42025-12-310.9%
Q12026-04-03-6.7%
Q22026-07-035.6%
Integer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.96-30.0%
20232023-12-31USD 2.7238.9%
20242024-12-31USD 3.3924.5%
20252025-12-31USD 2.89-14.7%
Integer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-266.7%
Q42025-12-3124.3%
Q12026-04-03-65.2%
Q22026-07-0343.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$464.11M

-1.8%

Gross Profit

$112.94M

+5.3%

Gross Margin

24.34%

N/A

Market Cap

$4.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$387.20K

N/A

Employees

11,000

N/A

Net Income

$23.61M

-36.2%

EBITDA

$67.96M

-22.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$21.38M

-7.6%

Total Debt

$1.36B

+3.3%

Accounts Receivable

$338.73M

-16.5%

Inventory

$288.06M

+8.1%

Long Term Debt

$1.36B

+3.4%

Short Term Debt

$8.21M

-8.0%

Return on Assets

3.75%

N/A

Return on Invested Capital

5.44%

N/A

Free Cash Flow

$37.04M

+49.0%

Operating Cash Flow

$59.74M

+36.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LIVNLivaNova PLC
$80.03+0.08%
CONConcentra Group Holdings Parent, Inc.
$34.70-0.72%
HAEHaemonetics Corporation
$105.00-1.50%
UFPTUFP Technologies, Inc.
$299.95-1.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$45.35-0.06%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$123.05+0.06%
NVDANvidia
$227.98+0.09%
INTCIntel
$92.09+0.04%

Questions About ITGR

What is the current price of Integer?

Integer is trading at $125.30 per share.

What is the 52-week range for Integer?

Over the past 52 weeks, Integer has traded between $62.00 and $126.14.

How much debt does Integer have?

As of the most recent reporting period, Integer reported total debt of $1.36B.

How much cash does Integer have on hand?

Integer reported $21.38M in cash and cash equivalents in its most recent financial results.

What is Integer’s dividend yield?

Integer does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.